reMind Interviews: Psychedelics Today: Alexa Jesse: Director of Sales & Strategic Partnerships
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Senate Democrats Reintroduce Comprehensive Cannabis Descheduling Bill, Renewing Push for Federal Reform
WASHINGTON, D.C. - The push for comprehensive federal Cannabis reform has returned to the U.S. Senate with the reintroduction of the Cannabis Administration and Opportunity Act (CAOA), a sweeping piece of legislation that would remove ...
California’s Cannabis Promise Remains Unfulfilled: Why Racial Disparities in Cannabis Arrests Continue to Shame the Golden State
SACRAMENTO- Nearly a decade after California voters approved adult-use Cannabis, the state has become one of the world's largest legal Cannabis markets. Billions of dollars have flowed through licensed businesses, thousands of jobs have been ...
FDA Finalizes Psychedelic Drug Guidance and Schedules September Public Hearing
WASHINGTON, D.C., The US FDA has established clearer expectations for psychedelic clinical trials while inviting public input on how the therapies could eventually be delivered in supervised healthcare settings. The U.S. Food and Drug Administration ...
